SCHEMBL29638104

SCHEMBL29638104

CCN(CC)CCSc1nc(Nc2ccc(F)c(Cl)c2)n2nccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPKAPK2 P49137 10/20 0.45
▸ CDK2 P24941 8/20 0.43
▸ CHEK2 O96017 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CSNK1D P48730 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ MAPKAPK3 Q16644 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MAP2K1 Q02750 1/20 0.41
▸ MAPKAPK5 Q8IW41 1/20 0.41
▸ EGFR P00533 6/20 0.37
▸ KDR P35968 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.36
▸ ERBB2 P04626 2/20 0.35
▸ ERBB4 Q15303 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638106 0.83 EGFR (0.48) EGFRERBB2ERBB4
SCHEMBL29638112 0.79 MAPKAPK2 (0.49) MAPKAPK2CDK2CHEK2CDK1CSNK1D
SCHEMBL29638107 0.73 EGFR (0.35) EGFRMAPTSMN1; SMN2
SCHEMBL29638120 0.70 EGFR (0.44) EGFR
SCHEMBL17188519 0.65 GRM4 (0.44) MAPKAPK2CDK2CHEK2CDK1CSNK1D
SCHEMBL10891277 0.64 MCHR1 (0.52) EGFRKDRMAPTSMN1; SMN2
SCHEMBL10892542 0.63 SMN1; SMN2 (0.50) EGFRKDRMAPTSMN1; SMN2
SCHEMBL3024611 0.61 MAPKAPK2 (0.50) MAPKAPK2CDK2CHEK2KDRMAPT
SCHEMBL28375085 0.61 TSHR (0.46) MAPTSMN1; SMN2
SCHEMBL12769217 0.60 METAP2 (0.42) CDK2CDK1CDK5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110950871-B 2-substituted-4-arylamino pyrazolotriazine derivative and application thereof in preparing antitumor drugs 陕西师范大学 2022-05-17 — — CN claimed
CN-110950871-B 2-substituted-4-arylamino pyrazolotriazine derivative and application thereof in preparing antitumor drugs 陕西师范大学 2022-05-17 — — CN disclosed
Send feedback